Indometacin eyedrops

A technology of indomethacin and eye drops, applied in sensory diseases, anti-infective drugs, drug combinations, etc., can solve problems such as retention, systemic side effects, and less obvious curative effects, and achieve inhibition of cyclooxygenase activity and release Inflammatory effect, the effect of simple production method

Inactive Publication Date: 2004-08-04
赵珊
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] At present, although there are many drugs used to treat eye injuries such as uveitis, conjunctivitis, and keratitis and inflammation caused by eye surgery in ophthalmology, their curative effects are not obvious. Commonly used drugs such as cortisone acetate eye drops liquid, dexamethasone eye drops, etc., but because some ey

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0007] Examples of parts by weight of the raw materials included in the present invention are: indomethacin 40, polyethylene glycol-4003200, sodium sulfite 8, borax 48, boric acid 176, and water for injection 8000.

[0008] The molecular formula of indomethacin of the present invention is: C 19 H 16 CINO 4

[0009] The shape of the present invention is: a light yellow clear liquid with a PH value of 6.5 to 8.5.

[0010] The production method of the embodiment of the present invention is as follows: A. Weighing: accurately weigh indomethacin, sodium sulfite, borax, and boric acid into the above-mentioned parts by weight using a prescribed scale or balance, and put them in a clean container for later use; B. Preparation :Take a heavy part of water for injection 8000 and place it in a clean ingredient tank (1), add sodium sulfite 8, borax 48, and boric acid 176 by weight while stirring, fully dissolve it, seal it, and boil it in water at 100°C for 30 minutes. , Cool to room temperat...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

An indometacin eyedrops for treating ophthalmopathy including the non-infective inflammation caused by operating is prepared from indometacin, polyethanediol-400, sodium sulfite, borax, boric acid and the water for injection.

Description

1. Technical field [0001] The invention relates to a medicine for treating eye diseases, in particular to an indomethacin eye drop. 2. Background technology [0002] At present, although there are many drugs used to treat eye injuries such as uveitis, conjunctivitis, and keratitis and inflammation caused by eye surgery in ophthalmology, their curative effects are not obvious. Commonly used drugs such as cortisone acetate eye drops Liquid, dexamethasone eye drops, etc., but because some of the eye drops belong to hormone drugs, which have the effect contrary to clinical treatment, so the scope of application is not wide enough. Domestic clinical use of indomethacin preparations mostly stays in the traditional oral administration, which often causes systemic side effects, which is the deficiency of the existing drugs for treating eye diseases. 3. Contents of the invention [0003] The purpose of the present invention is to invent a kind of indomethacin eye drop, this eye dr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/405A61P27/02A61P31/00
Inventor 赵珊
Owner 赵珊
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products